low grade ovarian serous adenocarcinoma
Showing 1 - 3 of 3
Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- Ovarian Cancer
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Scottsdale, Arizona
- +46 more
Dec 29, 2022
Patients With Low Grade Ovarian or Peritoneal Tumors
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- +5 more
- Biospecimen Collection
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States
Completed
- Borderline Ovarian Serous Tumor
- +5 more
- Laboratory Biomarker Analysis
- +3 more
-
Los Angeles, California
- +48 more
Dec 2, 2020